Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02214706Terminated
Randomised, open-label trial of sirolimus in port-wine stain (4 arms), sponsored by Erasmus MC. Primary endpoint: Percentage clearance assessed colorimetrically at 10 weeks. Started Jul 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02214706.